Osaic Holdings
RGNX icon

Osaic Holdings’s Regenxbio RGNX Stock Holding History

Osaic Holdings’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.9K Sell
1,663
-55
-3% -$456 ﹤0.01% 6168
2026
Q1 		$14.4K Buy
1,718
+266
+18% +$2.79K ﹤0.01% 6074
2025
Q4 		$20.9K Hold
1,452
– – ﹤0.01% 5857
2025
Q3 		$13.1K Buy
1,452
+960
+195% +$8.49K ﹤0.01% 6198
2025
Q2 		$4.04K Buy
492
+217
+79% +$1.82K ﹤0.01% 6657
2025
Q1 		$1.97K Buy
275
+8
+3% +$60 ﹤0.01% 6604
2024
Q4 		$2.06K Sell
267
-213
-44% -$2K ﹤0.01% 6585
2024
Q3 		$5.04K Buy
480
+23
+5% +$280 ﹤0.01% 6192
2024
Q2 		$5.35K Sell
457
-368
-45% -$5.73K ﹤0.01% 6135
2024
Q1 		$17.4K Sell
825
-724
-47% -$12.9K ﹤0.01% 5442
2023
Q4 		$27.8K Sell
1,549
-1,215
-44% -$21.4K ﹤0.01% 5301
2023
Q3 		$45.5K Buy
2,764
+59
+2% +$1.07K ﹤0.01% 5060
2023
Q2 		$54.1K Sell
2,705
-212
-7% -$4.08K ﹤0.01% 4888
2023
Q1 		$55.1K Sell
2,917
-3,407
-54% -$75.4K ﹤0.01% 4879
2022
Q4 		$144K Buy
6,324
+2
+0% +$45 ﹤0.01% 4133
2022
Q3 		$167K Buy
6,322
+324
+5% +$9.61K ﹤0.01% 3915
2022
Q2 		$147K Sell
5,998
-493
-8% -$12.3K ﹤0.01% 4076
2022
Q1 		$215K Buy
6,491
+229
+4% +$6.36K ﹤0.01% 3970
2021
Q4 		$204K Buy
6,262
+934
+18% +$31.8K ﹤0.01% 3922
2021
Q3 		$223K Sell
5,328
-11,116
-68% -$400K ﹤0.01% 3809
2021
Q2 		$639K Buy
16,444
+1,217
+8% +$43.5K ﹤0.01% 2756
2021
Q1 		$519K Buy
15,227
+8,849
+139% +$377K ﹤0.01% 2825
2020
Q4 		$290K Buy
6,378
+4,766
+296% +$167K ﹤0.01% 3146
2020
Q3 		$45K Buy
1,612
+293
+22% +$9.55K ﹤0.01% 4379
2020
Q2 		$49K Sell
1,319
-142
-10% -$5.29K ﹤0.01% 4200
2020
Q1 		$48K Buy
+1,461
New +$60.9K ﹤0.01% 4000

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Osaic Holdings's RGNX Position: Q2 2026 in Review

Osaic Holdings reduced its Regenxbio (RGNX) stake by 3.2% in Q2 2026, selling an estimated $456 and leaving 1,663 shares worth $19.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6168.

Osaic Holdings first reported a position in RGNX in Q1 2020 and has held it in 26 quarters since. The position peaked at $639K in Q2 2021. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Osaic Holdings held 1,663 shares of Regenxbio worth $19.9K as of Q2 2026.
  • Osaic Holdings sold 55 Regenxbio shares in Q2 2026, an estimated $456.
  • Regenxbio made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6168 holding.
  • Osaic Holdings first reported a position in Regenxbio in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Regenxbio position peaked at $639K in Q2 2021.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.